Sentences with phrase «vaccine research at»

He is currently an Assistant Professor and the Principal Investigator of the Viral Dynamics laboratory at the Center for Virology and Vaccine Research at the BIDMC.

Aeras will highlight the progress being made in TB vaccine research at the 5th Global Forum on TB Vaccines in New Delhi, India, February 20 - 23, 2018.

«We previously showed that adenovirus vector - based HIV - 1 vaccine candidates offered partial protection against SIV when given alone,» said lead author Dan H. Barouch, M.D., Ph.D., director of the Center for Virology and Vaccine Research at BIDMC and professor of medicine at Harvard Medical School.

«The pace of preclinical and early clinical development for Zika vaccines is unprecedented,» said Barouch, corresponding author and director of the Center for Virology and Vaccine Research at BIDMC.

Hanneke Schuitemaker, senior vice-president for vaccine research at Crucell, moved there a year ago from the University of Amsterdam in the Netherlands.

One goal of the study is to demonstrate the prevalence of H. influenzae in the region, explains Joel Ward, director of the Center for Vaccine Research at the University of California, Los Angeles, and scientific adviser to IVI.

«When viruses are unavailable for work in the lab, that is really a downside,» says Larry Smith, vice president of vaccine research at Vical Inc. in San Diego.

Not exact matches

The vaccine could even be described as «holistic,» according to Fred Ramsdell, vice president of research at the nonprofit Parker Institute.

«If they could figure out a way to streamline, it would be a lot better,» said Kim Janda, a professor of chemistry at the Scripps Research Institute in La Jolla, California, who leads a team of researchers developing a vaccine that would prevent fentanyl overdoses by keeping the drug from reaching the brain.

My older sister started her research on vaccines when she had kids, and since I was a teenager at the time, I read the articles and books she had to make my own decision.

Now a Stay At Home Mom, she hates molds and bandwagons, so she researches every aspect of her family life and is determined to be purposeful in living... no soap operas, bonbons, store diapers or vaccines for her!

Though it has not made any decision I have had to make easier, at least I am making it with my eyes open (Dr. Sears admits that in general doctors don't actually know anything about vaccines, he wrote the book when he actually started doing research and realized parents had legitimate concerns.

At 10:30 a.m., U.S. Senate Minority Leader U.S. Chuck Schumer will urge the U.S. Department of Health and Human Services to increase research, vaccine development and treatment strategies to help stamp out tick - borne diseases like Lyme disease, Albany Medical Center, B Entry, Patient Pavilion, Floor E, corner of Myrtle Avenue and New Scotland Avenue, Albany.

A publicly owned drug research and production utility, operating at cost for public benefit instead of private profit, would use high revenues from drugs that are taken daily or frequently in order to subsidize research and production of low - revenue drugs like vaccines for Ebola, malaria, and other infectious diseases that are used once.

«HIV - 1 viruses transmitted at birth are resistant to antibodies in mother's blood: New research supports creation of vaccine to boost mother's immune response to HIV - 1 before delivery.»

The long - term persistence of CD8αα + T cells where initial infection occurs may explain why patients have asymptomatic recurrences of genital herpes because these cells constantly recognize and eliminate the virus, according to Jia Zhu, Ph.D., corresponding author, research assistant professor in Laboratory Medicine at the University of Washington and an affiliate investigator in the Fred Hutch Vaccine and Infectious Disease Division.

Dr Alice Forster, study author and Cancer Research UK scientist at University College London, said: «Although around 87 per cent of girls in the UK do have the vaccine it's concerning to see that some girls from some ethnic minority groups feel they don't need to have it.

Robert Arao, MPH, a biostatistician at Group Health Research Institute, did a statewide survey — the first of its kind — to assess what doctors think and do about flu vaccines for pregnant women.

Whether the work is done at government institutions, universities or drug companies, the biotechnology boost to vaccine research is creating new opportunities to do vital work.

«The best explanation for what we are seeing is that frequently, after exposure to HIV, a few cells in the genital tract are infected, without establishment of a systemic infection,» says senior investigator Eric Hunter, PhD, professor of pathology and laboratory medicine at Emory University School of Medicine, Emory Vaccine Center, and Yerkes National Primate Research Center.

Scientists led by Hunter at Emory Vaccine Center / Center for AIDS Research teamed up with lead author Jonathan Carlson, PhD, and colleagues at Microsoft Research.

At the Ohio State Agricultural Research and Development Center in Wooster, immunologist Douglas Hodgins inoculated cows with a recombinant synthetic rotavirus vaccine a week before their expected calving date.

A spokesperson for the journal's publisher, PLOS, wrote in an email that a committee on «dual use research of concern» at the journal unanimously agreed that the benefits of publication, including «the potential improvements in vaccine development» outweighed the risks.

Now a research team, led by investigators at the Duke Human Vaccine Institute and the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), has tracked rare potent antibodies in an HIV - infected individual and determined sequential structures that point to how they deresearch team, led by investigators at the Duke Human Vaccine Institute and the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), has tracked rare potent antibodies in an HIV - infected individual and determined sequential structures that point to how they deResearch Center of the National Institute of Allergy and Infectious Diseases (NIAID), has tracked rare potent antibodies in an HIV - infected individual and determined sequential structures that point to how they developed.

«Based on epidemiological studies, the 9vHPV vaccine could prevent approximately 90 percent of cervical cancer, 90 percent of HPV - related vulvar and vaginal cancer, 70 to 85 percent of high - grade cervical disease in females, and approximately 90 percent of HPV - related anal cancer and genital warts in males and females worldwide,» explained Anna R. Giuliano, Ph.D., Director of the Center for Infection Research in Cancer at Moffitt.

«We could visualize this complex dance between the virus and the antibody and understand exactly how the virus was teaching the antibody to be a broadly neutralizing antibody,» said Peter D. Kwong, Ph.D., chief of the Structural Biology Section at the NIAID Vaccine Research Center.

The advantage of Novavax's approach is that a vaccine can be made rapidly and in high volume, compared with the egg - based approach that's used today, says Ted Ross, an associate professor of microbiology and molecular genetics at the University of Pittsburgh's Center for Vaccine Researchvaccine can be made rapidly and in high volume, compared with the egg - based approach that's used today, says Ted Ross, an associate professor of microbiology and molecular genetics at the University of Pittsburgh's Center for Vaccine ResearchVaccine Research (CVR).

The findings build on earlier research suggesting that the high - dose vaccine may be better at preventing influenza virus infections and other flu - related outcomes in seniors, including office visits and hospitalizations, compared to the standard - dose vaccine.

Research by Saad Omer, an epidemiologist at the Emory Vaccine Center in Atlanta, Georgia, points out similar abuses: he and his colleagues have found that medical exemptions are up to six times more common in states that have lax medical - exemption requirements or don't allow philosophical exemptions.

Healthy adults mounted strong immune responses after receiving an investigational whole inactivated Zika virus vaccine, according to interim analyses of three Phase 1, placebo - controlled, double - blind trials conducted at Beth Israel Deaconess Medical Center (BIDMC), Walter Reed Army Institute of Research (WRAIR), and Saint Louis University School of Medicine.

This could lead to new HIV vaccine strategies that are able to stimulate the rare precursors of these protective antibodies,» says Professor Lynn Morris, from the National Health Laboratory Service in the Wits School of Pathology who leads the research team at the NICD.

«We are pleased to have demonstrated such a potent and durable immune response to the vaccine,» said the study's lead author, Sita Awasthi, PhD, a research associate professor of Infectious Diseases at Penn. «If found effective in clinical trials, the vaccine will have a huge impact on reducing the overall prevalence of genital herpes infections and could reduce new HIV infections as well, especially in high - burden regions of sub-Saharan Africa.»

The German biotech CureVac, for example, has brought mRNA - based vaccines for rabies and cancer to clinical trials, and Karikó now heads a research team at BioNTech in Mainz, Germany, that focuses on mRNA - based drugs.

The research, led by a scientist at the University of Maryland School of Maryland (UM SOM) Center for Vaccine Development (CVD), was published recently in the journal Proceedings of the National Academy of Sciences.

Ingo Potrykus at the Swiss Federal Institute of Technology is engineering a novel strain of rice fortified with extra iron and vitamin A. Charles Arntzen, president of the Boyce Thompson Institute for Plant Research at Cornell University, is working on perhaps the most ambitious genetically engineered food of all: an edible vaccine.

A research team at the Montreal Children's Hospital from the Research Institute of the McGill University Health Centre (RI - MUHC) is bringing them hope with a potential vaccine that nudges the immune response away from developing alresearch team at the Montreal Children's Hospital from the Research Institute of the McGill University Health Centre (RI - MUHC) is bringing them hope with a potential vaccine that nudges the immune response away from developing alResearch Institute of the McGill University Health Centre (RI - MUHC) is bringing them hope with a potential vaccine that nudges the immune response away from developing allergies.

A team of scientists at the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases, part of NIH, created VRC07 - αCD3 under the leadership of VRC Director John R. Mascola, M.D.; former VRC Director Gary J. Nabel, M.D., Ph.D.; and Richard A. Koup, M.D., VRC deputy director and chief of its immunology laboratory.

But influenza vaccine research completed before that time by Yoshihiro Kawaoka's group at the University of Wisconsin, Madison, may demonstrate «the risk of curtailing so - called [GOF] studies,» wrote Jon Cohen in a Wednesday ScienceInsider.

A research team at The University of Texas at El Paso is one step closer to developing an effective human vaccine for cutaneous leishmaniasis, a tropical disease found in Texas and Oklahoma, and affecting some U.S. troops stationed in Afghanistan and Iraq.

Despite years of trying, scientists still haven't created an HIV vaccine that can protect people against the virus, says Alan Aderem, a biologist at the Center for Infectious Disease Research in Seattle.

«It's not something that will be a panacea for all [cocaine] addicts,» says John Shields, senior vice president of research at Cantab Pharmaceuticals, a British company that recently bought ImmuLogic's vaccine program.

The new research is at odds with other studies that cleared the vaccine of responsibility.

Now scientists at The Scripps Research Institute (TSRI) have developed a method to analyze the glycan shield on HIV's protective outer glycoprotein, developed as a potential HIV vaccine candidate.

Sitting at the nexus of vaccine research and manufacturing, she's charged with speeding commercialization of new shots and increasing the reach of existing ones.

Already scientists at Human Genome Sciences in Rockville, Maryland — a biotech company affiliated with Venter's research institute — have begun working on a more effective vaccine against Haemophilus.

The first live - attenuated Zika vaccine still in the development stage completely protected mice against the virus after a single vaccination dose, according to new research from The University of Texas Medical Branch at Galveston and Instituto Evandro Chagas at the Ministry of Health in Brazil.

What most encourages Black, in addition to the new breakthrough in blood - brain barrier research, are the results of a Phase 1 clinical trial of an anticancer vaccine that began at the institute in 1998.

Trials of the vaccine therapy are planned to start later this year at Massachusetts General Hospital in Boston, Johns Hopkins Medical Center in Baltimore, the Queensland Institute of Medical Research (QIMR) in Brisbane and the Royal Netherlands Cancer Institute in Amsterdam.

Meanwhile, research continues at St. Jude and elsewhere to develop more effective flu vaccines, particularly for high - risk groups, including the elderly, pregnant women and obese individuals.

This makes the development of an effective vaccine to protect against infection, as well as antiviral therapy to combat already - existing infections, particularly challenging,» says Dr. Grant Hansman, a virologist who leads the CHS Research Group on Noroviruses at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and Heidelberg University.